文献速递肾癌与肾肿瘤

肿瘤大小与小肾肿块主动监测中>0.5 cm/年生长速率及延迟干预相关

Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance.
PubMed 文献 · BJU Int · 2025-01-28

基于前瞻性多机构DISSRM登记中456例主动监测的小肾肿块患者,评估肿瘤大小与生长速率事件(>0.5 cm/年)及延迟干预的关联。中位随访40.1个月,128例(28%)发生生长速率事件,80例(18%)接受延迟干预。较大肿瘤大小是生长速率事件和延迟干预的独立预测因素(均P<0.05),2.9 cm截断值可能为患者咨询提供有价值信息。

要点

  • 在456例主动监测的小肾肿块患者中,28%发生>0.5 cm/年生长速率事件,18%接受延迟干预。
  • 较大肿瘤大小是生长速率事件和延迟干预的独立预测因素(均P<0.05)。
  • 采用2.9 cm截断值并考虑肿瘤大小随时间变化时关联最强,可能为患者咨询提供信息。

核心结论

  • 较大肿瘤大小与主动监测的小肾肿块患者的生长速率事件和延迟干预独立相关。
  • 2.9 cm截断值可能为患者咨询提供有价值的信息。

研究设计与样本

  • 查询前瞻性、多机构DISSRM登记中影像学间隔≥6个月的主动监测患者,共456例。
  • 追踪肿瘤大小随时间变化,生长速率>0.5 cm/年定义为生长速率事件。
  • 采用多变量复发事件和时间事件Cox回归模型评估肿瘤大小与生长速率事件(主要结局)及延迟干预(次要结局)的关联。

主要发现

  • 主动监测患者中位(四分位距)随访40.1(26.4-71.2)个月,期间128例(28%)发生≥1次生长速率事件,80例(18%)接受延迟干预。
  • 在多变量分析中,肿瘤大小作为连续变量和二分变量(预设2 cm和计算2.9 cm截断值)均为生长速率事件和延迟干预的独立预测因素(均P<0.05)。
  • 当考虑肿瘤大小随时间变化并应用2.9 cm截断值时,关联最强。

局限性

  • 研究受限于小肾肿块混合肿瘤病理的惰性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between tumour size and the growth rate (GR) of small renal masses (SRMs) in patients managed by active surveillance (AS). MATERIALS AND METHODS: We queried the prospective, multi-institutional Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) registry for patients on AS with an imaging interval of ≥6 months, identifying 456 patients. We tracked tumour size over time; a GR >0.5 cm/year was defined as a GR event. We used multivariable recurrent events and time-to-event Cox regression modelling to evaluate the association between tumour size and GR events (primary outcome) and tumour size and delayed intervention (DI; secondary outcome). We tested tumour size as a continuous variable and dichotomised tumour size by predefined (2-cm) and calculated (2.9-cm) cutoffs. We calculated the cutoff using maximally selected rank statistics and time to progression, defined according to the DISSRM registry. RESULTS: The median (interquartile range) follow-up of patients on AS was 40.1 (26.4-71.2) months, during which 128 patients (28%) had ≥1 GR event, and 80 (18%) underwent DI. Larger tumour size was an independent predictor for GR events and DI when tested as a continuous and a dichotomous variable in multivariable analyses (all P < 0.05). The association was strongest when accounting for the change in tumour size over time and when applying the 2.9-cm cutoff. The study is limited by the mixed tumour pathology inert to SRMs. CONCLUSION: Larger tumour size was independently associated with GR events and DI for patients with SRMs on AS. A 2.9-cm cutoff may provide valuable information for patient counselling.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Pallauf M, Rezaee M, Elias R, et al. Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance. BJU Int. 2025. PMID: 39873312. doi:10.1111/bju.16651

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。